February 13, 2025 - 18:35

In a significant boost for investors, major stock indices experienced a notable surge on Thursday, with the Nasdaq Composite leading the charge by closing 1.5% higher. The S&P 500 followed closely, registering an increase of over 1%. This positive momentum in the markets was largely attributed to the latest inflation data released in the morning, specifically the January Producer Price Index (PPI), which provided a sense of relief amid ongoing economic concerns.
Additionally, the decision by President Trump to delay the implementation of reciprocal tariffs until April further fueled market optimism. Investors reacted positively to this news, alleviating fears of immediate trade tensions that could impact economic growth. Analysts and market experts have pointed to these developments as critical factors driving the recent rally, highlighting the importance of inflation data and trade policies in shaping market sentiment.
As the trading day concluded, the overall market sentiment reflected a cautious yet optimistic outlook, with many looking ahead to upcoming economic indicators and their potential impact on market dynamics.
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...